Aiping Tong

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Venues

Signal transduction and targeted therapy

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Clinical & translational immunology

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Zhengyu Yu, Hexian Li, Qizhong Lu, Zongliang Zhang, Aiping Tong, Ting Niu
Fc receptor-like 5 (FCRL5)-directed CAR-T cells exhibit antitumor activity against multiple myeloma. Signal transduction and targeted therapy 9 (1) (2024)
Zhengyu Yu, Hexian Li, Qizhong Lu, Zongliang Zhang, Aiping Tong, Ting Niu
Fc receptor-like 5 (FCRL5)-directed CAR-T cells exhibit antitumor activity against multiple myeloma. Signal transduction and targeted therapy 9 (1) (2024)
Zhengyu Yu, Hexian Li, Qizhong Lu, Zongliang Zhang, Aiping Tong, Ting Niu
Fc receptor-like 5 (FCRL5)-directed CAR-T cells exhibit antitumor activity against multiple myeloma. Signal transduction and targeted therapy 9 (1) (2024)
Zhixiong Zhu, Hexian Li, Qizhong Lu, Zongliang Zhang, Jia Li, Zeng Wang, Nian Yang, Zhengyu Yu, Chen Yang, Yongdong Chen, Huaqing Lu, Wei Wang, Ting Niu, Chunlai Nie, Aiping Tong
mRNA-Engineered CD5-CAR-γδT CD5- Cells for the Immunotherapy of T-Cell Acute Lymphoblastic Leukemia. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Zhengyu Yu, Hexian Li, Qizhong Lu, Zongliang Zhang, Aiping Tong, Ting Niu
Fc receptor-like 5 (FCRL5)-directed CAR-T cells exhibit antitumor activity against multiple myeloma. Signal transduction and targeted therapy 9 (1) (2024)
Dan Li, Xianling Guo, Kun Yang, Yuening Yang, Weilin Zhou, Yong Huang, Xiao Liang, Jinhua Su, Lin Jiang, Jing Li, Maorong Fu, Haixia He, Jinrong Yang, Hua-Shan Shi, Hanshuo Yang, Aiping Tong, Nianyong Chen, Jian-Kun Hu, Qing Xu, Yu-Quan Wei, Wei Wang
EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors. Science advances 9 (48) (2023)
Lin Zhao, Jia Zhao, Kunhong Zhong, Aiping Tong, Da Jia
Targeted protein degradation: mechanisms, strategies and application. Signal transduction and targeted therapy 7 (1) (2022)
Shasha Zhao, Yuelong Wang, Nian Yang, Min Mu, Zhiguo Wu, Hexian Li, Xin Tang, Kunhong Zhong, Zongliang Zhang, Cheng Huang, Ting Cao, Meijun Zheng, Guoqing Wang, Chunlai Nie, Hui Yang, Gang Guo, Liangxue Zhou, Xi Zheng, Aiping Tong
Genome-scale CRISPR-Cas9 screen reveals novel regulators of B7-H3 in tumor cells. Journal for immunotherapy of cancer 10 (6) (2022)
Cheng Huang, Xing Duan, Jichao Wang, Qingqing Tian, Yangmei Ren, Kepan Chen, Zongliang Zhang, Yuanyou Li, Yunyu Feng, Kunhong Zhong, Yuelong Wang, Liangxue Zhou, Gang Guo, Xiangrong Song, Aiping Tong
Lipid Nanoparticle Delivery System for mRNA Encoding B7H3-redirected Bispecific Antibody Displays Potent Antitumor Effects on Malignant Tumors. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2022)
Rui Zhang, Xiaohua Jiang, Jingxin Qiao, Zeng Wang, Aiping Tong, Jinliang Yang, Shengyong Yang, Li Yang
Antimicrobial peptide DP7 with potential activity against SARS coronavirus infections. Signal transduction and targeted therapy 6 (1) (2021)
Xin Tang, Yuelong Wang, Jianhan Huang, Zongliang Zhang, Fujun Liu, Jianguo Xu, Gang Guo, Wei Wang, Aiping Tong, Liangxue Zhou
Administration of B7-H3 targeted chimeric antigen receptor-T cells induce regression of glioblastoma. Signal transduction and targeted therapy 6 (1) (2021)
Xin Tang, Fujun Liu, Zhiyong Liu, Yi Cao, Zongliang Zhang, Yuelong Wang, Jianhan Huang, Shuangming Fan, Shasha Zhao, Yaxing Chen, Gaowei Li, Shan Wang, Mei-Jun Zheng, Yating Hu, Hongjian Li, Caiying Jiang, Meijia Yang, Hui Yang, JianGuo Xu, Gang Guo, Aiping Tong, Liangxue Zhou
Bioactivity and safety of B7-H3-targeted chimeric antigen receptor T cells against anaplastic meningioma. Clinical & translational immunology 9 (6) (2020)
Jingyun Yang, Wei Wang, Zimin Chen, Shuaiyao Lu, Fanli Yang, Zhenfei Bi, Linlin Bao, Fei Mo, Xue Li, Yong Huang, Weiqi Hong, Yun Yang, Yuan Zhao, Fei Ye, Sheng Lin, Wei Deng, Hua Chen, Hong Lei, Ziqi Zhang, Min Luo, Hong Gao, Yue Zheng, Yanqiu Gong, Xiaohua Jiang, Yanfeng Xu, Qi Lv, Dan Li, Manni Wang, Fengdi Li, Shunyi Wang, Guanpeng Wang, Pin Yu, Yajin Qu, Li Yang, Hongxin Deng, Aiping Tong, Jiong Li, Zhenling Wang, Jinliang Yang, Guobo Shen, Zhiwei Zhao, Yuhua Li, Jingwen Luo, Xiao-Zhong Peng, Wenhai Yu, Mengli Yang, Jingwen Xu, Junbin Wang, Haiyan Li, Haixuan Wang, Dexuan Kuang, Panpan Lin, Zhengtao Hu, Wei Guo, Wei Cheng, Yanlin He, Xiangrong Song, Chong Chen, Zhihong Xue, Shaohua Yao, Lu Chen, Xuelei Ma, Siyuan Chen, Maling Gou, Wei Jin Huang, You-Chun Wang, Changfa Fan, Zhixin Tian, Ming Shi, Fu-Sheng Wang, Lunzhi Dai, Mingshan Jiang, Gen Li, Guangyu Wang, Yong Peng, Zhiyong Qian, Canhua Huang, Johnson Yiu-Nam Lau, Zhenglin Yang, Yuquan Wei, Xiaobo Cen, Xiaozhong Peng, Chuan Qin, Kang Zhang, Guang-Wen Lu, Yanping Qian
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature 586 (7830) (2020)
Tao Li, Lihui He, Changcheng Li, Mei Kang, Yingjie Song, Yibo Zhu, Yalin Shen, Ninglin Zhao, Chang Zhao, Jing Yang, Qin Huang, Xingyu Mou, Aiping Tong, Jinliang Yang, Zhenling Wang, Chengjie Ji, Hong Li, Hong Tang, Rui Bao
Molecular basis of the lipid-induced MucA-MucB dissociation in Pseudomonas aeruginosa. Communications biology 3 (1) (2020)

Aiping Tong.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Aiping Tong